IPM.ai

Curated by Signal

AI-powered precision medicine platform optimizing the product lifecycle for rare disease therapies

Overview

AI-powered precision medicine platform optimizing the product lifecycle for rare disease therapies. It offer assistance in various phases of the product lifecycle, including market assessment, patient finding and profiling, treatment journey mapping, HCP identification, patient and HCP segmentation, referral network mapping, specialty inference, KOL discovery, and HCP activation.

Key facts

Founded: 2017
Headquarters: Cambridge, United States
Stage: Sign up to view
Industry: Health Technology

Contact

Primary office: Sign up to view
Email: Sign up to view
Phone: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Elucidata
Provider of an AI and cloud-based data analytics tool for the life sciences research
Health TechnologySan Francisco, United States
Alternative Health Directory Online
Provider of an online listing platform for alternative health professionals
Health TechnologyBrooklyn, United States
Exl Pharmacy
Drug price comparison platform
Health TechnologyNew York City, United States

About IPM.ai

What does IPM.ai do?

AI-powered precision medicine platform optimizing the product lifecycle for rare disease therapies.

Where is IPM.ai headquartered?

IPM.ai is headquartered in Cambridge, United States.

When was IPM.ai founded?

IPM.ai was founded in 2017.

Which sector is IPM.ai in?

IPM.ai operates in Health Technology.

Who are IPM.ai's competitors?

Companies similar to IPM.ai include Elucidata, Alternative Health Directory Online, and Exl Pharmacy.